Colorectal Cancer Medications

500mg

Utilized to target malignant cell proliferation, this chemotherapy agent is indicated to support the management of advanced colorectal, breast, and gastric carcinomas.

500mg

Developed to target cancerous growths by utilizing systemic conversion to therapeutic agents that inhibit DNA synthesis.